Kabuki syndrome (or Kabuki-macrosomia syndrome) is a rare genetic disorder characterized by a unique set of physical, intellectual, and medical features. It was first described in 1981 by Japanese scientists, which gave rise to its name, based on the Japanese Kabuki theater, noted for its expressive makeup. The main clinical manifestations include characteristic changes in facial and body anatomy, developmental delay, hypotonia, and the presence of various anomalies. External signs are often combined with internal pathologies, such as heart defects, kidney disorders, and hearing disorders. In addition, patients may experience a wide range of cognitive impairment, from mild mental retardation to more profound disorders.
History of the disease and interesting historical facts
An interesting aspect of Kabuki syndrome is its relatively recent discovery. The disease was first recorded in the early 1980s, when Japanese pediatricians described several patients with similar clinical manifestations. The descriptions of the syndrome formed the basis for subsequent research, and at this stage the main genetic abnormalities were identified. Since then, an international community of doctors and researchers has developed reviews of the involvement of various genes and mutations, such as KMT2D and KDM6A, which confirmed the genetic nature of the disease. An important step in the study of the syndrome was the creation of a global database that allowed researchers to exchange information and results. The advent of modern molecular genetic technologies has opened new horizons in understanding the causes and mechanisms of Kabuki syndrome.
Epidemiology
Kabuki syndrome is considered a rare disorder, but the exact prevalence varies by region. The incidence is reported to be between 1 in 32,000 and 1 in 86,000 live births. The disorder occurs equally in males and females. About 70% patients have typical features of the syndrome, while the rest may exhibit various combinations of symptoms. Epidemiological studies suggest that the syndrome is more common in certain ethnic groups, which may be due to genetic factors in the population.
Genetic predisposition to this disease
Kabuki syndrome is caused by mutations in genes that play an important role in regulating cell growth, differentiation, and organ formation. Research has identified two key genes that are highly associated with the syndrome: KMT2D (formerly known as MLL2) and KDM6A.
— Gene KMT2D:
— Responsible for the regulation of gene transcription and is necessary for normal development.
— Mutations in this gene are associated with a more severe form of the disease.
— Gene KDM6A:
— Associated with the maintenance of stromal architecture and tissue development.
— Mutations in this gene can lead to less pronounced clinical manifestations.
In addition, other less common mutations have been identified in various genes, but KMT2D and KDM6A are the main regulators associated with the syndrome.
Risk factors for the development of this disease
At present, scientists have not established the exact mechanism that causes mutations in genes associated with Kabuki syndrome. However, there are some factors that can increase the likelihood of developing the disease:
- Family history: Having previously affected family members can significantly increase the risk of inheriting mutations.
- Gender Identity: KDM6A genetic mutations are most often recessive and bias towards males.
- Environmental factors: Exposure to chemicals such as alkaloids or toxins during pregnancy may affect the health of the fetus.
- Parental age: Advanced maternal age at pregnancy may be associated with an increased risk of chromosomal abnormalities.
Diagnosis of this disease
Diagnosis of Kabuki syndrome is usually based on clinical data using specific examination methods:
- Main symptoms: Patients may exhibit characteristics such as abnormal eye shape, characteristic skin changes, and developmental delays.
- Laboratory tests: Blood tests to detect mutations in the KMT2D and KDM6A genes play an important role in confirming the diagnosis.
- Radiological examinations: X-ray examinations can reveal various abnormalities of the skeleton and organ structures.
- Other diagnostic tests: Genetic testing and cardiac imaging may reveal the presence of secondary abnormalities.
- Differential diagnosis: It is important to exclude other genetic disorders with similar clinical manifestations, such as Treacher Collins and Wolf-Hirschhorn syndromes.
Treatment
Treatment of Kabuki syndrome is usually multi-level and complex. Given the wide range of symptoms, therapeutic approaches may vary:
- General treatment: Patients primarily require symptom monitoring and supportive care. A multidisciplinary approach, including pediatricians, geneticists, and internists, is key.
- Pharmacological treatment: it is possible to use drugs to correct concomitant diseases, such as cardiac pathologies or metabolic disorders.
- Surgical treatment: Depending on the nature of the anomalies, intervention may be required to correct the resulting defects.
- Other treatments include physical therapy and rehabilitation measures to improve motor function and development.
List of drugs used to treat this disease
There are currently no specific medications for the treatment of Kabuki syndrome. The main treatment is aimed at managing symptoms and may include:
- Drugs to support cardiovascular function.
- Medicines to control hypertension and heart rhythms.
- Stimulants to increase motor activity and reflexes.
- Optimization of metabolism with the help of vitamin complexes.
Disease monitoring
Monitoring the condition of patients with Kabuki syndrome is an important part of treatment. The following aspects are taken into account:
- Checkpoints: Periodic check-ups with a pediatrician and specialists to assess physical and cognitive development.
- Prognosis: Patients with the syndrome can make significant progress, but many require ongoing support.
- Complications: It is important to consider possible co-morbidities, such as cardiac problems or endocrine disorders, which may require an individualized approach to treatment.
Age-related features of the disease
Kabuki syndrome can present differently depending on the patient's age. For example:
- Young children: a high degree of developmental delay and the presence of characteristic facial features are noted.
- Preschool age: slow speech development and difficulties in social adaptation.
- Adolescents: Changes in cognitive function and emotional disturbances may occur.
- Adults: continued monitoring for possible organ and systemic disease.
Questions and Answers
- What are the main symptoms of Kabuki syndrome?
Key symptoms include characteristic facial features (such as "first" eye shape), developmental delay, hypotonia, and possible internal organ abnormalities. - How is Kabuki syndrome diagnosed?
Diagnosis is made on the basis of clinical picture, laboratory tests (genetic testing) and radiological studies. - What treatment is indicated for Kabuki syndrome?
Treatment is comprehensive and includes supportive therapy, surgical interventions if necessary, and rehabilitation measures. - Is Kabuki syndrome hereditary?
Yes, Kabuki syndrome can be hereditary, and mutations in genes can be passed from parents to children. - What is the prognosis for patients with Kabuki syndrome?
Prognosis depends on the severity of symptoms, but many patients make significant progress with appropriate treatment and support.
Advice from Dr. Oleg Korzhikov
According to Dr. Oleg Korzhikov, important aspects for parents of children with Kabuki syndrome are:
- Support early development: It is necessary to actively engage with children to help them develop physical and cognitive functions.
— Regular medical examinations: visits to a pediatrician and specialists to monitor health status.
- Social integration: It is important to create conditions for interaction with peers so that children can develop their social skills.
- Health education: Parents need to be well informed about the disease to make informed decisions about treatment and care.
